loader image
COVID19 UPDATES
Slide
Slide
Slide 1
previous arrow
next arrow

Our Services

For Products and Establishments registration at FDA

Verification Portal

Check the List of Approved FDA
Authorizations

eServices Portal

New Online Application System for FDA Authorizations

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2022-1081-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na beripikadong pekeng...
Read More

FDA Advisory No.2022-1078 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “AA MEDICAL+HEALTHCARE NASAL OXYGEN CANNULA”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the...
Read More

FDA Advisory No.2022-1077 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product “READING GLASSES”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the...
Read More

FDA Advisory No.2022-1076 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product “MEDIPACK® GAUZE PADS (4” X 4” X 12 PLY 24 X 28 MESH)”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the...
Read More

FDA Advisory No.2022-1080-A || Babala sa Publiko tungkol sa Pagbili at Paggamit ng Beripikadong Pekeng Gamot na “Mefenamic Acid (Ponstan®) 500 mg Tablet”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng sumusunod na beripikadong pekeng gamot:...
Read More

FDA Advisory No.2022-1080 || Public Health Warning Against the Purchase and Use of the Verified Counterfeit Drug Product “Mefenamic Acid (Ponstan®) 500 mg Tablet”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the...
Read More

FDA Advisory No.2022-1081 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the...
Read More

FDA Advisory No.2022-1072 || INTERIM PROCESS FOR INTENDED LICENSE TO OPERATE VARIATION APPLICATIONS FOR VAPOR PRODUC T AND HEATED TOBACCO PRODUCT ESTABLISHMENTS

In accordance with the implementation of Administrative Order No. 2020-0055 entitled “Regulation  on Vapor Products and Heated Tobacco Products (HTPs)...
Read More

FDA Advisory No.2022-1071 || REITERATION ON THE PROCESSING OF LICENSE TO OPERATE (LTO) APPLICATION FOR VAPOR PRODUCT AND HEATED TOBACCO PRODUCT ESTABLISHMENTS

The Food and Drug Administration (FDA) would like to inform all concerned stakeholders that the requirement for a license to...
Read More

FDA Advisory No.2022-1075 || Public Health Warning Against the Purchase and Use of the Following Unregistered Medical Device Products:

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the...
Read More

Announcement

Seminar Venue for CDRRHR QPIRA Seminar on 19-20 June 2018
Seminar Venue for CDRRHR QPIRA Seminar Please be informed that the conduct of CDRRHR QPIRA Seminar on 19-20 June 2018, ...
Read More
Effectivity of the New Schedule of Fees
Please be informed that the Food and Drug Administration will be implementing its new schedule of fees effective 30 June ...
Read More
Intensified Campaign Against Counterfeit Pharmaceutical Products
The FDA is again reminding the public to be more vigilant in buying drug products as it has noted that ...
Read More
Shares